AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 33794354
Drug: Switch medications
RxNorm normalized name: witch hazel Medicated Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch medications from NRT to varenicline
Trial: 33794354
Drug: Intensify treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensify treatment to a higher CM reward schedule
Trial: 35780589
Drug: QLC (Qilong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QLC (Qilong capsule) combined with conventional treatment (CT)
Trial: 34728131
Drug: Neoadjuvant and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant and concurrent androgen deprivation therapy (ADT) for 6 months starting 4 months before prostate radiotherapy
Trial: 34728131
Drug: Concurrent and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent and adjuvant ADT for 6 months starting simultaneously with prostate radiotherapy
Trial: 32796442
Drug: Intravitreal dexamethasone
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal dexamethasone implant injection
Trial: 35807864
Drug: Calcitriol treatment
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcitriol treatment (in vitro)
Trial: 36314323
Drug: CIRRHOS product
RxNorm normalized name: Fritillaria cirrhosa bulb extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIRRHOS product (2 gr L-carnitine and 150 mg magnesium) for 16 weeks
Trial: 37604396
Drug: Lozenge containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lozenge containing 2% arginine and probiotics (Lacticaseibacillus rhamnosus, LGG® and Lactobacillus paracasei subsp. paracasei)
Trial: 33549047
Drug: Fecal microbiota
RxNorm normalized name: Fecal Microbiota
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fecal microbiota transplantation (FMT) capsules, administered once a week for 4 consecutive weeks
Trial: 33549047
Drug: Placebo capsules,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules, administered once a week for 4 consecutive weeks
Trial: 35209934
Drug: Fecal microbiota
RxNorm normalized name: Fecal Microbiota
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fecal microbiota transplantation (FMT) capsules
Trial: 32140867
Drug: Morning administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning administration of IFN‐β1a 44 µg (Rebif)
Trial: 32140867
Drug: Evening administration
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening administration of IFN‐β1a 44 µg (Rebif)
Trial: 35822289
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (OC) during hypercapnia
Trial: 35822289
Drug: Not taking
RxNorm normalized name: Lamictal 25mg-100mg Tablet Starter Kit (For Patients Not Taking Enzyme-Inducing Drugs or Valproate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not taking oral contraceptives (NOC) during hypercapnia
Trial: 36376830
Drug: Arginine‐containing toothpaste,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arginine‐containing toothpaste, Colgate Total Daily Repair (PC)
Trial: 36376830
Drug: Fluoride‐free toothpaste,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride‐free toothpaste, Colgate Oral Care (NC)
Trial: 32232363
Drug: Glucagon (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucagon (2 pmol/kg/min intravenous infusion)
Trial: 32232363
Drug: Vehicle infusion
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle infusion (rate-matched)
Trial: 33187503
Drug: Hypnotherapeutic group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnotherapeutic group program (5 weekly sessions of 120-min duration, plus 5 hypnosis audiorecords for individual practice at home, plus an educational booklet for stress coping)
Trial: 35450813
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of PCAT-RCA of ≥−70.5 HU and LAP burden >4%
Trial: 35450813
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of LAP burden and PCAT attenuation
Trial: 35627704
Drug: Kitchen diet
RxNorm normalized name: Kitchen sage oil
DrugBank: Sage oil (DB11199)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kitchen diet (n = 32; 1.2 g fiber in 100 mL)
Trial: 35627704
Drug: Nutrison Energy®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrison Energy® (n = 14; 0.02 g fiber in 100 mL)
Trial: 35627704
Drug: Nutrison Diason
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrison Diason Energy HP® (n = 13; 1.8 g fiber in 100 mL)
Trial: 34848169
Drug: Ranibizumab 0.5
RxNorm normalized name: RANIBIZUMAB 0.5MG/0.05ML INJ,OPH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab 0.5 mg every 4 weeks (Rq4)
Trial: 32768938
Drug: Pure western
RxNorm normalized name: Dream Pure BB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pure western medicine therapy (PWM group)
Trial: 33080291
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg nicotine
Trial: 36209381
Drug: Fractional CO2
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional CO2 laser treatment followed by topical application of triamcinolone acetonide
Trial: 36209381
Drug: Dermapen treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dermapen treatment followed by topical application of triamcinolone acetonide
Trial: 36966023
Drug: Dexamethasone 0.15
RxNorm normalized name: dexamethasone 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.15 mg/kg
Trial: 33719795
Drug: Digital Cognitive
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital Cognitive Behavioral Therapy for Insomnia (CBTI)
Trial: 33481328
Drug: sorafenib +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sorafenib + vitamin K2 (menatetrenone, 45 mg daily, orally)
Trial: 36100413
Drug: 20% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% glucose solution
Trial: 35904046
Drug: Esketamine nasal
RxNorm normalized name: esketamine Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esketamine nasal spray (ESK) plus standard of care (SoC)
Trial: 35904046
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray (PBO) plus standard of care (SoC)
Trial: 32598909
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone 600 mg per day from 11 to 14 until 34 weeks’ gestation
Trial: 39680411
Drug: CBD 400
RxNorm normalized name: CBD
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBD 400 mg
Trial: 34719731
Drug: THC 8
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 8 mg + CBD 4 mg (THC + CBDlow)
Trial: 34719731
Drug: THC 12
RxNorm normalized name: THC
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC 12 mg + CBD 400 mg (THC + CBDhigh)
Trial: 32438716
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy (PBMT) with laser irradiation, applied on days 0, 3, 7, and 14 for 2-4 minutes each session
Trial: 33973828
Drug: Photobiomodulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photobiomodulation therapy using 660, 800, and 970 nm wavelengths with 30 kJ of energy for 3 minutes
Trial: 34193163
Drug: Government supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Government supplements due to SARS-CoV-2 pandemic
Trial: 34808036
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg fenofibrate
Trial: 33210772
Drug: Risk indicator
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risk indicator - Implant malposition (too vestibular)
Trial: 33210772
Drug: Risk indicator
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risk indicator - Implant brand (Nobel vs. Straumann)
Trial: 33210772
Drug: Protective indicator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective indicator - Proton pump inhibitors
Trial: 33210772
Drug: Protective indicator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective indicator - Anticoagulants
Trial: 34636710
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (group therapy on diet and physical activity modification)
Trial: 32551827
Drug: Hatha yoga
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hatha yoga classes (25 minutes, twice weekly for 12 weeks)
Trial: 32341237
Drug: Polaprezinc (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polaprezinc (150 mg/d) plus pantoprazole (40 mg/d)
Trial: 32341237
Drug: Rebamipide (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebamipide (300 mg/d) plus pantoprazole (40 mg/d)
Trial: 32312302
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care + daily motivational e-messages to maintain the log book
Trial: 32312302
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care + e-device for measuring step count (fit bit) + daily motivational e-messages
Trial: 36378671
Drug: Aleglitazar (PPAR-α/γ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aleglitazar (PPAR-α/γ agonist)
Trial: 36068298
Drug: Catecholamines (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catecholamines (specific dosage and duration not mentioned)
Trial: 32645137
Drug: GDF‐15 levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GDF‐15 levels in the highest quartile (≥358 pg/mL)
Trial: 33805883
Drug: β-Hydroxy-β-Methylbutyrate (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-Hydroxy-β-Methylbutyrate (7.5 g) and L-Arginine α-Ketoglutarate (10 g) supplementation
Trial: 32315057
Drug: Intravenous zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous zoledronic acid (5 mg in 100 mL saline solution)
Trial: 32369036
Drug: Virtual Reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual Reality Cognitive Behavioral Therapy (VR-CBT)
Trial: 33894169
Drug: Sevuparin (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevuparin (18 mg/kg per day)
Trial: 33894169
Drug: Placebo (NaCl,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (NaCl, 0.9% solution)
Trial: 33738495
Drug: Cabazitaxel (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel (25 mg/m2 IV Q3W, prednisone, G-CSF)
Trial: 32356185
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (SOF/DCV-based therapy)
Trial: 34381155
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg/24 h for 7 days
Trial: 34381155
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg/12 h for 7 days
Trial: 35550645
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy (LT)
Trial: 35305111
Drug: Human fibrinogen
RxNorm normalized name: Human fibrinogen
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human fibrinogen concentrate (70 mg/kg)
Trial: 35704027
Drug: 3.2 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.2 g/day CLA
Trial: 32684362
Drug: 3.2 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.2 g/day placebo (sunflower oil)
Trial: 35088760
Drug: Transcutaneous electrical
RxNorm normalized name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous electrical acustimulation (TEA) at acupuncture points LI4 and ST36, performed for one hour twice daily for one month.
Trial: 32716114
Drug: tivantinib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tivantinib (120 mg bid)
Trial: 36078628
Drug: Combined Treatment
RxNorm normalized name: POISON IVY/OAK/SUMAC EXTRACTS COMBINED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined Treatment (DN + HA)
Trial: 36281667
Drug: Icapamespib 10
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 10 mg
Trial: 36281667
Drug: Icapamespib 20
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 20 mg
Trial: 36281667
Drug: Icapamespib 30
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 30 mg
Trial: 36281667
Drug: Icapamespib 20
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 20 mg (multiple ascending dose)
Trial: 36281667
Drug: Icapamespib 30
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 30 mg (multiple ascending dose)
Trial: 36281667
Drug: Placebo (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multiple ascending dose)
Trial: 36281667
Drug: Icapamespib 30
RxNorm normalized name: Icapamespib
DrugBank: Icapamespib (DB18106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib 30 mg (bioavailability)
Trial: 36281667
Drug: Icapamespib (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icapamespib (oral solution)
Trial: 33905405
Drug: Methadone (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (0.08 mg/kg)
Trial: 32969202
Drug: Iberdomide 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 0.03 mg
Trial: 32969202
Drug: Iberdomide 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 0.1 mg
Trial: 32969202
Drug: Iberdomide 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 0.3 mg
Trial: 32969202
Drug: Iberdomide 1
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 1 mg
Trial: 32969202
Drug: Iberdomide 2
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 2 mg
Trial: 32969202
Drug: Iberdomide 4
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 4 mg
Trial: 32969202
Drug: Iberdomide 6
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 6 mg
Trial: 32969202
Drug: Iberdomide 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 0.3 mg once daily for 14 days
Trial: 32969202
Drug: Iberdomide 1
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 1 mg once daily for 28 days
Trial: 32969202
Drug: Iberdomide 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 0.3 mg once daily for 28 days
Trial: 32969202
Drug: Iberdomide 1
RxNorm normalized name: Iberdomide
DrugBank: Iberdomide (DB12101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iberdomide 1 mg once daily for 7 days with a 7-day washout, then once daily for 7 more days
Trial: 37622634
Drug: Micronized raloxifene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized raloxifene 45 mg
Trial: 37622634
Drug: Conventional raloxifene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional raloxifene 60 mg
Trial: 32674743
Drug: Higher intake
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher intake of cruciferous vegetables (>44.6 g/d)
Trial: 32674743
Drug: Lower intake
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower intake of cruciferous vegetables (<15.0 g/d)
Trial: 34279747
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of pseudoephedrine
Trial: 34789230
Drug: Chlorine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorine treatment of water reservoirs
Trial: 34789230
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment of water reservoirs
Trial: 35091204
Drug: Behavioral cough
RxNorm normalized name: Pediaclear Cough
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral cough suppression therapy (BCST) plus 6 treatment sessions involving exposure to nebulized capsaicin in progressively larger concentrations (n = 8)
Trial: 35091204
Drug: BCST plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCST plus 6 sessions of exposure to a single subthreshold dose of capsaicin (sham; n = 6)
Trial: 35240703
Drug: Meditation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meditation group (daily use of a mindfulness‐focused meditation app)
Trial: 35588706
Drug: Perspectives app-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perspectives app-based cognitive behavioral therapy (CBT) for 12 weeks
Trial: 35588706
Drug: Perspectives app-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perspectives app-based cognitive behavioral therapy (CBT)
Trial: 33769952
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment for 3 years
Trial: 36239675
Drug: OTT166 eyedrops
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OTT166 eyedrops (2.5% or 5%) administered BID for 28 days
Trial: 33342524
Drug: Packed Promise
RxNorm normalized name: pramoxine
DrugBank: Pramocaine (DB09345)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Packed Promise intervention (monthly food boxes with $38 food value and $15 check for fruits and vegetables)
Trial: 33661180
Drug: Sham Electroconvulsive
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham Electroconvulsive Therapy
Trial: 33661180
Drug: Other Novel
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other Novel Therapies
Trial: 36060146
Drug: Oral allopurinol
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral allopurinol tablets, 100 mg, 2 times a day
Trial: 32975441
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of cannabis with 6.7% delta-9-tetrahydrocannabinol (THC)
Trial: 36218395
Drug: Rhomboid intercostal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhomboid intercostal and subserratus plane (RISS) block + intravenous patient‐controlled analgesia
Trial: 36218395
Drug: Intravenous patient‐controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient‐controlled analgesia
Trial: 34816917
Drug: Combined doxofylline
RxNorm normalized name: doxofylline
DrugBank: Doxofylline (DB09273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined doxofylline and salbutamol treatment for 1 week
Trial: 34816917
Drug: Doxofylline treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxofylline treatment for 1 week
Trial: 32347591
Drug: High-frequency pulse
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency pulse (HFP) TLNS plus physical therapy (PT)
Trial: 32347591
Drug: Low-frequency pulse
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency pulse (LFP) TLNS plus physical therapy (PT)
Trial: 35436940
Drug: Nimodipine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (60 mg)
Trial: 39363095
Drug: Metformin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin therapy
Trial: 34864768
Drug: Music Upper
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Music Upper Limb Therapy-Integrated (MULT-I)
Trial: 33078636
Drug: Multi-Ingredient Performance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-Ingredient Performance Supplement (MIPS)
Trial: 32727613
Drug: PrEP with
RxNorm normalized name: Alcohol Prep with Benzocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PrEP with hydroxychloroquine (400mg daily for 4 days, then 400mg weekly for 6 months)
Trial: 38451604
Drug: Opioid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid therapy